T. Rowe Price Associates’s Provention Bio, Inc. Common Stock PRVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-25,091
| Closed | -$605K | – | 3026 |
|
|
2023
Q1 | $605K | Sell |
25,091
-6,046
| -19% | -$146K | ﹤0.01% | 2022 |
|
|
2022
Q4 | $329K | Buy |
31,137
+1,578
| +5% | +$16.7K | ﹤0.01% | 2334 |
|
|
2022
Q3 | $134K | Buy |
29,559
+9,411
| +47% | +$42.7K | ﹤0.01% | 2658 |
|
|
2022
Q2 | $81K | Buy |
20,148
+272
| +1% | +$1.09K | ﹤0.01% | 2795 |
|
|
2022
Q1 | $145K | Buy |
+19,876
| New | +$145K | ﹤0.01% | 2772 |
|
|
2021
Q3 | – | Sell |
-10,063
| Closed | -$85K | – | 2996 |
|
|
2021
Q2 | $85K | Buy |
+10,063
| New | +$85K | ﹤0.01% | 2855 |
|